The FluoroDot assay is a versatile, low-cost, adaptable test that uses a plasmonic-fluor, a plasmon-enhanced nanolabel that is 16,000 times brighter than conventional fluorescence labels and has a signal-to-noise ratio of nearly 30 times higher (Cell Reports Method, August 5, 2022).

The ultrabright emission allows the user to see small quantities of secreted protein, which they are unable to do in existing assays, and measure the high-resolution signals digitally using the dot pattern per cluster or spot with a custom-built algorithm. The assay also enables concurrent visualization of two types of proteins from individual cells.

The study team used proteins secreted from both human and mouse cells, including immune cells infected with Mycobacterium tuberculosis. With the assay, they were able to assess how individual cells in a population responded to infection, specifically, to see which cells were secreting and in which direction.

The patent-pending plasmonic fluor technology is licensed by the Office of Technology Management at Washington University in St. Louis to Auragent Bioscience.

Researchers identify how bacterium that causes tuberculosis evolves rapidly
A new study has identified how the bacterium that causes tuberculosis can evolve rapidly in response to new environments, providing insights into how...

Researchers grow functional pancreatic beta cells from stem cells
A research group has demonstrated that stem cells can form cells that closely mimic normal pancreatic islets, in terms of both structure and function....

4D microscopy reveals how malaria parasite invades red blood cells
A state-of-the-art microscopy technique has allowed Australian researchers to view parasite invasions in 4D. Using this technology, the team was able...